AACR logo

More articles from Companion Diagnostic, Pharmacogenomic, and Cancer Biomarkers

A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas
Avanthi Tayi Shah, Tej D. Azad, Marcus R. Breese, Jacob J. Chabon, Emily G. Hamilton, Krystal Straessler, David M. Kurtz, Stanley G. Leung, Aviv Spillinger, Heng-Yi Liu, Inge H. Behroozfard, Frederick M. Wittber, Florette K. Hazard, Soo-Jin Cho, Heike E. Daldrup-Link, Kieuhoa T. Vo, Arun Rangaswami, Allison Pribnow, Sheri L. Spunt, Norman J. Lacayo, Maximilian Diehn, Ash A. Alizadeh, E. Alejandro Sweet-Cordero

Molecular Cancer Therapeutics Oct 2021, 20 (10) 2016-2025; DOI: 10.1158/1535-7163.MCT-20-0987
ERK Inhibition Improves Anti–PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma
Kelly E. Henry, Kyeara N. Mack, Veronica L. Nagle, Mike Cornejo, Adam O. Michel, Ian L. Fox, Maria Davydova, Thomas R. Dilling, Nagavarakishore Pillarsetty, Jason S. Lewis

Molecular Cancer Therapeutics Oct 2021, 20 (10) 2026-2034; DOI: 10.1158/1535-7163.MCT-20-1112
Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD–Positive AML
Megan E. Zavorka Thomas, Xiyuan Lu, Zahra Talebi, Jae Yoon Jeon, Daelynn R. Buelow, Alice A. Gibson, Muhammad Erfan Uddin, Lindsey T. Brinton, Julie Nguyen, Meghan Collins, Alessia Lodi, Shannon R. Sweeney, Moray J. Campbell, Douglas H. Sweet, Alex Sparreboom, Rosa Lapalombella, Stefano Tiziani, Sharyn D. Baker

Molecular Cancer Therapeutics Sep 2021, DOI: 10.1158/1535-7163.MCT-21-0071
Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer
Julia Judd, Nagla Abdel Karim, Hina Khan, Abdul Rafeh Naqash, Yasmine Baca, Joanne Xiu, Ari M. VanderWalde, Hirva Mamdani, Luis E. Raez, Misako Nagasaka, Sachin Gopalkrishna Pai, Mark A. Socinski, Jorge J. Nieva, Chul Kim, Antoinette J. Wozniak, Chukwuemeka Ikpeazu, Gilberto de Lima Lopes, Alexander I. Spira, W. Michael Korn, Edward S. Kim, Stephen V. Liu, Hossein Borghaei

Molecular Cancer Therapeutics Sep 2021, DOI: 10.1158/1535-7163.MCT-21-0201
Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible
Taylor J. Jensen, Aaron M. Goodman, Christopher K. Ellison, Kimberly A. Holden, Shumei Kato, Lisa Kim, Gregory A. Daniels, Kerry Fitzgerald, Erin McCarthy, Prachi Nakashe, Amin R. Mazloom, Eyad Almasri, Graham McLennan, Daniel S. Grosu, Marcia Eisenberg, Razelle Kurzrock

Molecular Cancer Therapeutics Aug 2021, DOI: 10.1158/1535-7163.MCT-20-1066
Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study
Hong Zheng, Yunong Gao, Hongyan Guo, Li Li, Qingshui Li, Heng Cui, An Lin, Lixin Sun, Yuanjing Hu, Shan Kang, Wei Duan, Lingya Pan, Shuzhen Wang, Yingjie Yang, Yunxia Li, Weimin Kong, Yang Xiang, Xiaofei Tian, Bin Ling, Chunfang Ha, Wenpei Bai

Molecular Cancer Therapeutics Sep 2021, 20 (9) 1735-1742; DOI: 10.1158/1535-7163.MCT-20-1064
Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent
Eddy S. Yang, Amin H. Nassar, Elio Adib, Opeyemi A. Jegede, Sarah Abou Alaiwi, Deborah L. Della Manna, David A. Braun, Mahsa Zarei, Heng Du, Sumanta K. Pal, Gurudatta Naik, Guru P. Sonpavde

Molecular Cancer Therapeutics Aug 2021, 20 (8) 1454-1461; DOI: 10.1158/1535-7163.MCT-20-1091
BRAF^V600E Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis
Chan-Juan Wang, Lei Cui, Hong-Hao Ma, Dong Wang, Li Zhang, Hong-Yun Lian, Wei-Jing Li, Qing Zhang, Tian-You Wang, Zhi-Gang Li, Rui Zhang

Molecular Cancer Therapeutics Jul 2021, 20 (7) 1316-1323; DOI: 10.1158/1535-7163.MCT-20-1075
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC
Hiroyuki Arai, Shu Cao, Francesca Battaglin, Jingyuan Wang, Natsuko Kawanishi, Ryuma Tokunaga, Fotios Loupakis, Sebastian Stintzing, Shivani Soni, Wu Zhang, Christoph Mancao, Bodour Salhia, Shannon M. Mumenthaler, Chiara Cremolini, Volker Heinemann, Alfredo Falcone, Joshua Millstein, Heinz-Josef Lenz

Molecular Cancer Therapeutics Jun 2021, 20 (6) 1153-1160; DOI: 10.1158/1535-7163.MCT-20-0649
Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases
Marika K.A. Koivu, Deepankar Chakroborty, Mahlet Z. Tamirat, Mark S. Johnson, Kari J. Kurppa, Klaus Elenius

Molecular Cancer Therapeutics Mar 2021, 20 (3) 564-576; DOI: 10.1158/1535-7163.MCT-20-0590

Main menu

User menu

Search

More articles from Companion Diagnostic, Pharmacogenomic, and Cancer Biomarkers

Pages

Articles

Info for

About MCT